Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm-shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such as Alzheimer’s disease, Parkinson's disease, and other neurological disorders.
The major factors that enhance the market growth are an increase in the geriatric population, a rise in the incidence of neurological & epidemic disorders, and the launch of innovative products for nerve repair & regeneration. However, stringent regulatory requirements delay product approvals, thereby restraining the market growth.
The nerve repair and regeneration market are segmented on the basis of surgery, product, and region. By surgery, the market is classified into direct neuropathy, nerve grafting, stem cell therapy, and neuromodulation surgery. The direct neuropathy segment is further sub-categorized into epineural repair, perineural repair,
and group fascicular repair. The nerve grafting segment is further sub-categorized into autografts, allografts, and xenografts. The neuromodulation surgery is further sub-categorized into external neuromodulation surgery and internal neuromodulation surgery.
By product, the market is divided into biomaterials and neuromodulation surgery devices. The biomaterials segment is further sub-categorized into nerve conduits, nerve protectors, nerve wraps, and nerve connectors. The neuromodulation surgery devices segment is further divided into external neuromodulation surgery and internal neuromodulation surgery. Externalneuromodulation surgery is further segmented into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. The internal neuromodulation surgery segment is divided into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and others. By region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA)
The major companies profiled in this report include Abbott Laboratories (U.S.), AxoGen Inc. (U.S.), Boston Scientific Incorporation (U.S.), Integra Lifesciences Corporation (U.S.), Medtronic plc (U.S.), NeuroPace, Inc., NeuroSigma, Polyganics B.V. (Netherlands
The major factors that enhance the market growth are an increase in the geriatric population, a rise in the incidence of neurological & epidemic disorders, and the launch of innovative products for nerve repair & regeneration. However, stringent regulatory requirements delay product approvals, thereby restraining the market growth.
The nerve repair and regeneration market are segmented on the basis of surgery, product, and region. By surgery, the market is classified into direct neuropathy, nerve grafting, stem cell therapy, and neuromodulation surgery. The direct neuropathy segment is further sub-categorized into epineural repair, perineural repair,
and group fascicular repair. The nerve grafting segment is further sub-categorized into autografts, allografts, and xenografts. The neuromodulation surgery is further sub-categorized into external neuromodulation surgery and internal neuromodulation surgery.
By product, the market is divided into biomaterials and neuromodulation surgery devices. The biomaterials segment is further sub-categorized into nerve conduits, nerve protectors, nerve wraps, and nerve connectors. The neuromodulation surgery devices segment is further divided into external neuromodulation surgery and internal neuromodulation surgery. Externalneuromodulation surgery is further segmented into transcutaneous electrical nerve stimulation and transcranial magnetic stimulation. The internal neuromodulation surgery segment is divided into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and others. By region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA)
The major companies profiled in this report include Abbott Laboratories (U.S.), AxoGen Inc. (U.S.), Boston Scientific Incorporation (U.S.), Integra Lifesciences Corporation (U.S.), Medtronic plc (U.S.), NeuroPace, Inc., NeuroSigma, Polyganics B.V. (Netherlands
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nerve repair and regeneration market analysis from 2020 to 2030 to identify the prevailing nerve repair and regeneration market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the nerve repair and regeneration market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global nerve repair and regeneration market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Biomaterials
- Neuromodulation Surgery Devices
By Surgery
- Stem Cell Therapy
- Neuromodulation Surgery
- Direct Neuropathy
- Nerve Grafting
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Fo Lamea
Key Market Players
- Abbott Laboratories
- Boston scientific inc
- Integra Lifesciences Corporation
- Medtronic plc
- Axogenic
- Stryker Corporation
- Checkpoint Surgical
- Polyganics
- Synovis Micro Companies Alliance
- OrthoMed, Inc
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT
CHAPTER 5: NERVE REPAIR AND REGENERATION MARKET, BY SURGERY
CHAPTER 6: NERVE REPAIR AND REGENERATION MARKET, BY REGION
CHAPTER 7: COMPANY LANDSCAPE
CHAPTER 8: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, Nerve Repair and Regeneration Market by Surgeries and Product Type: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global nerve repair and regeneration market was valued at $5,927 million in 2016, and is projected to garner13,938 million by 2023, registering a CAGR of 13.0% from 2017 to 2023. The neuromodulation surgeries segment contributed the highest share in 2016, owing to the increase in patients suffering from neurological disorders.The nerve repair and regeneration products market includes biomaterials and neurostimulation and neuromodulation devices. The techniques of nerve repair and regeneration assist to cure the disorders such as Alzheimers disease, Parkinsons diseases, and other neurological diseases. Increase in geriatric population, rise in prevalence of neurological & epidemic disorders, and launch of innovative products for nerve repair & regeneration are the major factors that drive the market growth. However, stringent regulatory requirements for product approvals act as a restraining factor for the market growth. Increase in investment by major medical diagnostics giants and improvement in healthcare facilities in Asia-Pacific provide growth opportunities for the market.
The neuromodulation surgeries segment contributed the highest share in 2016, owing to the increase in patients suffering from neural disorders. Neuromodulation surgery devices contributed the highest share in 2016, owing to the wide range of product offering for nerve repair. The North American market accounted for a significant share in the global market in 2016, owing to growth in number of patients suffering from neurological disorders.
Key Findings of the Nerve Repair and Regeneration Market:
In 2016, the neuromodulation surgery segment accounted for the highest share of the global nerve repair and regeneration market.The neuromodulation surgeries devices segment contributed the highest revenue to the global market in 2016.
The nerve conduits segment is projected to grow at a CAGR of 11.7% during the forecast period.
North America market is dominating the market with a share of over two-fifths of the market.
The major companies profiled in the report include AxoGen Inc. (U.S.), Baxter International (U.S.), Boston Scientific Incorporation (U.S.), Cyberonics Inc. (U.S.), Integra Lifesciences Corporation (U.S.), Medtronic Plc. (U.S.), Orthomed S.A.S. (France), Polyganics B.V. (Netherlands), St. Jude Medical (U.S.), and Stryker Corporation (U.S.).
Companies Mentioned
- Abbott Laboratories
- Boston scientific inc
- Integra Lifesciences Corporation
- Medtronic plc
- Axogenic
- Stryker Corporation
- Checkpoint Surgical
- Polyganics
- Synovis Micro Companies Alliance
- OrthoMed, Inc
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
